Log In
Print
BCIQ
Print
Print this Print this
 

ICT-107

  Manage Alerts
Collapse Summary General Information
Company ImmunoCellular Therapeutics Ltd.
DescriptionIntradermal dendritic cell-based therapeutic vaccine that targets 6 tumor-associated antigens
Molecular Target Dendritic cells
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma; Treat glioblastoma multiforme (GBM)
Regulatory Designation

U.S. - Orphan Drug (Treat glioblastoma multiforme (GBM));
EU - Orphan Drug (Treat glioblastoma)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today